Skip to content

E4 Pharmaceutical Consulting

E4 Biotechnology and Pharmaceutical Consulting. Providing product development (CMC), regulatory, QA/QC and project management support to companies developing new small-molecule drugs, biologics and medical devices.

Welcome!!

Categories

  • Regulatory (2)
    • Regulatory Strategy (1)
    • Regulatory Submissions (2)

E4 Pharmaceutical Consulting

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

RSS FDA News

  • How Stronger Site Relationships Improve Clinical Trial Performance 
    Clinical research has never been more complex.  Protocols demand more data. Study teams are asked to move faster. Global trials must accommodate local realities. At the same time, sites are balancing clinical care, administrative responsibilities, and participant expectations. These challenges are interconnected, and they have a direct impact on study performance.   For many organizations, the […]
  • AI in Clinical Research: Why Context, Trust, and Responsibility Matter
    Artificial intelligence is everywhere in our industry right now. Every company has an AI story. Every product claims to be AI-powered.   But if we’re being honest, AI itself is quickly becoming commoditized.   So the real question isn’t who is using AI.   It’s who is using it responsibly, meaningfully, and in a way that actually changes […]
  • How WCG Contract Intelligence Reduced Clinical Trial Agreement (CTA) Turnaround Time by 43%
    Ready to accelerate study startup?  Find out how leading institutions are using WCG to compress study startup timelines. The post How WCG Contract Intelligence Reduced Clinical Trial Agreement (CTA) Turnaround Time by 43% appeared first on WCG.
  • IRB and IBC Review for Gene Therapy and Cell Therapy Trials
    If you are looking to submit or have already submitted your study for IBC review with WCG, please contact us at ibcservices@wcgclinical.com for more information. Gene therapy and cell therapy studies require thorough ethical and biosafety oversight due to their technical complexity and potential risks to participants, staff, and the environment. Subject to applicable rules […]
  • Accelerating Activation by Overcoming Roadblocks
    The post Accelerating Activation by Overcoming Roadblocks appeared first on WCG.

RSS Pharma Times

  • Kupando doses first patient in phase 1 trial
    KUP101 enters clinic for advanced solid tumours
  • First-in-class house dust mite allergy treatment now available in Scotland
    SMC acceptance offers new option for patients
  • NHS backs new treatment option for cystinosis
    Delayed‑release mercaptamine approved for routine use
  • Fridge‑free vaccine shows global potential
    Stablepharma’s thermostable td shot delivers strong phase 1 data
  • Lexeo wins FDA RMAT status for LX2020
    Regulator backs gene therapy for PKP2-ACM
  • EHP Awards 2027 open for entries
    Programme celebrates partnership excellence
Proudly powered by WordPress / Theme: Shoreditch by Automattic.